Clinical Trial Update: PCSK9 Inhibitors in Combination With Advanced Treatment Strategies for the Treatment of Advanced Colorectal Cancer With pMMR/MSS [Phase 2]

View source ↗

Summary

Phase 2 trial exploring PCSK9 inhibitors in combination with advanced treatment strategies for advanced colorectal cancer with pMMR/MSS. The study status is NOT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• PCSK9 inhibitor (class) (PCSK9 inhibitor)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Colorectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING